Why DSOs Are Paying Premium Multiples for Dental Practices
The dental support organization market has fundamentally changed the economics of practice ownership over the past decade. Private equity capital has flooded into the DSO model because it offers something rare in healthcare: a fragmented market with predictable recurring revenue, high margins relative to other healthcare verticals, and a clear consolidation playbook. There are approximately 200,000 practicing dentists in the United States, the vast majority in solo or small group practices, and DSOs currently control only about 15% to 20% of the market. That gap between current penetration and potential market share is what drives the aggressive acquisition appetite.
For practice owners, the result is a seller's market that has persisted for several years and shows no signs of cooling. Well-run dental practices with $1.5 million or more in annual revenue are routinely commanding 9x to 12x adjusted EBITDA from DSOs. Multi-location groups with 3 to 5 offices, shared infrastructure, and associate dentists in place are achieving 13x to 15x EBITDA because the DSO avoids the integration complexity of bolting together disparate solo practices.
To put that in concrete dollar terms: a single-location practice collecting $2.2 million per year with adjusted EBITDA of $440,000 could sell for $3.96 million to $5.28 million. A 3-location group collecting $6 million with adjusted EBITDA of $1.1 million could sell for $14.3 million to $16.5 million. These are life-changing numbers for dentists who built their practices over 15 to 25 years, and they are available right now for practices that are properly prepared.
But the difference between a practice that achieves a 9x multiple and one that achieves a 12x multiple on the same EBITDA is $1.32 million on a $440,000 earnings base. That gap is almost entirely a function of financial preparation, deal process management, and negotiation strategy. This article covers the financial checklist that determines where your practice lands on that spectrum.
What DSOs Actually Look For in an Acquisition
Before diving into the financial preparation, it is worth understanding what makes a practice attractive, and unattractive, to a DSO buyer. DSOs are not buying your clinical skills. They are buying a cash flow stream that they believe they can maintain or grow after the transition. Every aspect of their evaluation comes back to that question.
Low overhead ratio. DSOs target practices with total overhead (all expenses excluding provider compensation) below 60% to 65% of collections. A practice at 55% overhead is significantly more attractive than one at 68% because the DSO sees more margin to capture and less risk that the practice is subsidized by unsustainably low operating costs that will normalize upward post-acquisition.
Clean and organized financials. DSOs employ sophisticated financial due diligence teams, often from Big Four accounting backgrounds. They will scrutinize three to five years of tax returns, monthly P&L statements, production reports by provider, and accounts receivable aging. Practices with incomplete records, inconsistent accounting methods, or unexplained fluctuations in revenue or expenses immediately trigger discounts or walk-aways.
Provider retention and diversification. A practice where the selling dentist generates 85% of production is a riskier acquisition than one where the seller generates 50% and two associates generate 25% each. DSOs know that patients have loyalty to their provider, not to the office. If the selling dentist reduces hours or leaves within 2 to 3 years, the DSO needs confidence that the remaining providers can sustain the revenue.
Active and growing patient base. DSOs track active patient count (patients seen within the last 18 to 24 months), new patient flow per month, and patient attrition rates. A practice with 2,500 active patients adding 40 new patients per month is healthier than one with 2,500 active patients adding 15. Even if current-year revenue is identical, the declining patient trend signals future revenue risk that DSOs will price into their offer.
Modern, well-maintained equipment. A DSO that acquires a practice and immediately needs to spend $200,000 on a new panoramic X-ray, operatory chairs, and a digital scanner will subtract that capital expenditure from their offer or structure it as a purchase price adjustment. Practices that have invested steadily in equipment maintenance and upgrades over the preceding 3 to 5 years avoid this discount.
EBITDA Normalization: The Most Impactful Pre-Sale Step
Adjusted EBITDA is the metric DSOs use to value your practice, and it is not the same number your accountant puts on your tax return. Normalized or adjusted EBITDA starts with your net income and adds back expenses that are either non-recurring, discretionary, or reflective of owner-operator choices rather than the true operating cost of the practice.
The add-backs that legitimately increase your adjusted EBITDA include the following categories, and getting them right is where most of the value creation happens.
Owner Compensation Normalization
This is typically the largest single adjustment. Most practice owners pay themselves through a combination of salary, distributions, retirement plan contributions, and personal expenses run through the business. The DSO does not care what you paid yourself. They care what it would cost to replace your clinical production with an employed associate dentist.
If you collected $1.8 million in personal production and paid yourself total compensation of $650,000, but the fair market replacement cost for an associate producing $1.8 million is $450,000 (25% of collections), the $200,000 difference is a legitimate EBITDA add-back. This single adjustment can increase your EBITDA by 30% to 50% and correspondingly increase your purchase price by $1.8 million to $2.4 million at a 9x to 12x multiple.
Personal Expenses and Discretionary Costs
Most dental practice owners run some personal expenses through the business. Vehicle payments, continuing education trips that double as vacations, meals and entertainment, family members on the payroll who perform limited work, and life insurance premiums are common examples. These expenses are legitimate tax deductions, but they are not required to operate the practice. Adding them back to EBITDA is appropriate as long as you can document that they are truly discretionary.
A word of caution: aggressive add-backs backfire. If you claim $120,000 in discretionary add-backs and the DSO's diligence team can only verify $60,000, you have damaged your credibility and the buyer will scrutinize every other number more aggressively. Be honest and conservative. Document every add-back with supporting evidence before the buyer asks for it.
Below-Market Rent Adjustment
If you own the building your practice operates in and charge the practice below-market rent, or no rent at all, EBITDA will be overstated relative to what a buyer will actually experience. DSOs will normalize rent to fair market value. If your practice pays $3,000 per month in rent for a space that would lease at $8,000 per month on the open market, the DSO will deduct $60,000 from EBITDA, which at a 10x multiple reduces the purchase price by $600,000.
The flip side is that you can often negotiate a long-term lease with the DSO at fair market rates for your property, creating a separate income stream of $96,000 per year. Structuring the real estate correctly, either as a separate sale, a long-term triple-net lease, or a leaseback arrangement, can recover more than the EBITDA adjustment in present value terms.
Understanding DSO Deal Structures
The purchase price is only one dimension of the deal. How that price is structured determines your actual financial outcome, and the structure of DSO deals has evolved significantly as the market has matured.
Cash at Close
Most DSO transactions deliver 65% to 75% of the total purchase price in cash at closing. For a $4 million deal, that is $2.6 million to $3.0 million in immediate liquidity. This is the portion of the deal with no contingencies, no risk, and no conditions beyond the standard closing adjustments. After capital gains taxes (currently 20% federal plus state taxes and the 3.8% net investment income tax), a seller netting $2.8 million in cash at close might retain approximately $2.0 million to $2.2 million after taxes. That is the number that funds your retirement, your next venture, or your investment portfolio.
Equity Rollup
The second component, typically 15% to 25% of the deal value, is equity in the parent DSO entity. In a $4 million deal, this is $600,000 to $1.0 million in equity that you do not receive as cash. Instead, you become a minority equity holder in the DSO platform alongside the private equity sponsor.
The equity roll is where the counterintuitive economics of DSO deals become apparent. The equity portion is often worth more than the cash portion over a 5- to 7-year horizon, but only if the DSO executes its growth strategy and achieves a successful exit. Here is the math. If you roll $800,000 in equity at the current 12x valuation, and the DSO grows and sells at a 15x valuation 5 years later, your $800,000 becomes $1.0 million (a 25% gain from multiple expansion alone, before accounting for EBITDA growth in the platform). If the DSO also doubles its aggregate EBITDA through acquisitions and organic growth, your $800,000 could become $2.0 million or more.
But this outcome is not guaranteed. If the DSO fails to execute, is overleveraged, or if the market cools, your equity could be worth less than what you rolled. The equity roll should be evaluated as a high-risk, high-reward investment, not as a guaranteed component of your purchase price. Sellers who need the full purchase price for retirement should negotiate for a higher cash percentage, even if it means accepting a slightly lower total headline number.
Earnout and Seller Notes
The remaining 5% to 15% is typically structured as an earnout, a seller note, or a combination. An earnout pays additional consideration if the practice achieves specified financial targets (usually revenue or EBITDA thresholds) over 1 to 3 years post-closing. A seller note is a promissory note from the DSO paying the balance over time, typically with 3% to 5% interest.
Earnout structures require careful negotiation. The targets must be achievable within your control. An earnout tied to revenue growth of 8% per year may be reasonable if you have historically grown at 6% to 10%. An earnout tied to EBITDA targets that the DSO can manipulate through overhead allocation or management fee structures is a trap. Insist that earnout calculations use the same accounting methodology as the closing EBITDA calculation, with a clear dispute resolution mechanism.
The Employment Agreement: Your Second Negotiation
Every DSO deal includes a post-closing employment agreement, typically for 3 to 5 years. The terms of this agreement directly affect your total financial outcome and your quality of life for the next half-decade.
Compensation structure. Most DSOs pay the selling dentist 25% to 30% of personal collections, which for a dentist collecting $1.5 million translates to $375,000 to $450,000 annually. Some DSOs offer a base salary plus production bonus structure. Negotiate for the higher of the two formulas. A dentist who shifts from working 4.5 days per week as an owner to 4 days per week as an employee while earning $400,000 with no overhead responsibility has achieved an attractive outcome.
Non-compete provisions. Virtually all DSO employment agreements include non-compete clauses restricting you from practicing within a specified radius (typically 10 to 25 miles) for 1 to 2 years after employment ends. These clauses affect your exit options if the DSO relationship deteriorates. Negotiate the tightest reasonable scope: shorter duration, smaller radius, and specific carve-outs for specialties you do not currently practice.
Schedule and clinical autonomy. Clarify in writing what clinical decisions remain yours (treatment planning, referral patterns, material and lab selection) and what the DSO controls (scheduling templates, fee schedules, staffing levels, vendor contracts). The most common source of post-sale dissatisfaction among dentists is the loss of clinical autonomy that was not clearly addressed in the employment agreement.
The 12-18 Month Pre-Sale Preparation Timeline
Sellers who engage financial advisors 12 to 18 months before marketing their practice consistently achieve 15% to 25% higher purchase prices than those who respond to an unsolicited DSO inquiry without preparation. The reason is straightforward: preparation gives you time to normalize EBITDA, clean up any financial issues, create a competitive bidding process, and negotiate from a position of strength rather than urgency.
Months 18 to 12 before sale: Engage a financial advisor and dental practice appraiser. Complete a preliminary valuation to identify the gap between current EBITDA and optimized EBITDA. Begin normalizing discretionary expenses, documenting add-backs, and addressing any financial weaknesses (declining patient counts, aged A/R, deferred equipment maintenance).
Months 12 to 6 before sale: Implement operational improvements identified in the preliminary assessment. If overhead is above 65%, identify specific cost reductions. If revenue is concentrated in the selling dentist, begin transitioning patients to associates. If the books have inconsistencies, engage an accountant to reconstruct clean financial statements for the trailing three years. Get a professional practice valuation that you can share with prospective buyers.
Months 6 to 0 before sale: Market the practice to 3 to 5 qualified DSOs simultaneously. Having multiple interested buyers is the single most effective negotiation lever. A practice that negotiates with one DSO accepts that DSO's terms. A practice that receives 3 letters of intent can negotiate the best terms from each and select the optimal combination of price, structure, and cultural fit.
The Valuation Gap You Cannot Afford to Ignore
Here is the calculation that should motivate every dentist considering a DSO sale. A practice with $400,000 in actual EBITDA as reported on tax returns, sold without preparation to the first DSO that makes an offer, might achieve an 8x multiple: $3.2 million. The same practice, with 18 months of preparation that normalizes EBITDA to $500,000, overhead reduced from 67% to 61%, and a competitive bidding process that pushes the multiple from 8x to 11x, sells for $5.5 million.
The difference is $2.3 million. The cost of the financial advisory, accounting cleanup, and practice valuation that produced this outcome is typically $30,000 to $75,000. That is a return on investment of 30x to 75x. There is no other financial decision in the life of a dental practice that offers this kind of leverage, and there is no good reason to leave it on the table.